The medical device manufacturer’s trading profit was $212 million in the second quarter, up from $198 million in 2008.
According to the report, Smith & Nephew’s total revenues for the year were down 6 percent from 2008 to $531 million, and officials cited a rise in deferred procedures for the drop in orthopedics.
Read the Business Journal’s report about Smith & Nephew’s second-quarter results.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
